Clinical Cosmetic and Investigational Dermatology · 2019 · 18 citations · 22 references
MedicineDermatologyPharmacotherapyAllergyDiagnostic MicrobiologyMedical MicrobiologyCream MicrobiologyImmunopathology Of SkinInflammatory Skin DiseasesInflammatory Skin DisordersSkin CareSkin MicrobiomeHyaluronic Acid TreatmentSeborrheic EczemaSkin Bacterial CommunitiesSkin Microbiome DiversitySkin Microbiome In DiseaseSkin Microbiome In HealthSkin Microbiome InteractionsSkin Site-specific Microbiomes
Objective: A new cream formulation containing hyaluronic acid 5%, complexed with a mix of a bacterial-wall-derived glycoprotein and peptide glycan complex (EDS), has been recently developed. We evaluated in a prospective, assessor-blinded, 6-week study the efficacy and tolerability of EDS in the treatment of facial seborrheic dermatitis (SD) and the effects on skin microbiota. Subjects and methods: Seventy-five subjects (mean age 46; 60 men) with moderate-severe SD of the face were enrolled. EDS cream was applied twice daily. The primary outcome was the evolution of the Investigator Global Assessment (IGA) score, evaluating erythema, scale/flaking, grade of seborrhea and itch. Superficial skin bacterial microbiome at baseline and after treatment was assessed, using the 16S rRNA gene methodology, in affected and non-affected face areas. Local tolerability was evaluated checking self-reported side effects at each visit. Results: Baseline IGA scores (mean±SD) was 10±3. The use of EDS reduced IGA score significantly by 70% at week 3 and by 88% at week 6. An increase in the abundance of Cutibacterium acnes genera associated with a significant drop of Staphylococcus genera presence was detected in affected areas. The ratio of relative abundance of genera Cutibacterium /Staphylococcus increased significantly after treatment in affected areas. The product was very well tolerated. Conclusion: Treatment with EDS applied twice daily for 6 consecutive weeks was associated with a reduction of the signs and symptoms of SD. Furthermore, after EDS cream treatment, a reequilibrating effect on facial skin microbiota was observed. The product was very well tolerated. Keywords: seborrheic dermatitis, skin microbiota, hyaluronic acid, assessor blinded trial
22
Muya Shu, Yanhan Wang, Jinghua Yu et al. · PLoS ONE · 2013 · 322 citations · Full text
KS Puri, KR Suresh, NJ Gogtay et al. · Journal of Postgraduate Medicine · 2009 · 294 citations · Full text
Yanhan Wang, Sherwin Kuo, Muya Shu et al. · Applied Microbiology and Biotechnology · 2013 · 292 citations · Full text
Yvonne M. DeAngelis, Christina M. Gemmer, Joseph R. Kaczvinsky et al. · Journal of Investigative Dermatology Symposium Proceedings · 2005 · 287 citations · Full text
Medicine, Dermatology, Microbiology +16
Microbiome dynamics of human epidermis following skin barrier disruption
Patrick L.J.M. Zeeuwen, Jos Boekhorst, Ellen H. van den Bogaard et al. · Genome biology · 2012 · 274 citations · Full text